The original article shows two mistakes, which are listed here:
The original article shows two mistakes, which are listed here:
1. In paragraph 6 of the section "Second-line therapy:
cabazitaxel and second-line hormone therapy" there was a mistake in line 6; instead of 0.65, it should have been written 0.74:
Overall survival was longer in the abiraterone group (14.8 months vs. 10.9 months; hazard ratio, 0.74; p < 0.001).
2. In the original version of this article two algorithms were referenced in section "Methodology", but were not included in the article. The missing algorithms are listed here:
The original article can be found online at http s://doi.org/10.1007 / s120 94-017-1783 -2. 
